Holen Sie sich die Stockscreener-App
135.57
1.18%
1.255
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$134.32
Offen:
$135.41
24-Stunden-Volumen:
2,479
Relative Volume:
0.00
Marktkapitalisierung:
$6.05B
Einnahmen:
$2.81B
Nettoeinkommen (Verlust:
$-294.68M
KGV:
-5.9437
EPS:
-22.8098
Netto-Cashflow:
$232.59M
1W Leistung:
+7.21%
1M Leistung:
+4.67%
6M Leistung:
+7.41%
1J Leistung:
+16.48%
1-Tages-Spanne:
$135.41
$136.69
1-Wochen-Bereich:
$127.75
$135.47
52-Wochen-Spanne:
$100.18
$139.67
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
136.69 | 5.61B | 2.81B | -294.68M | 232.59M | -22.81 |
ISRG
Intuitive Surgical Inc
|
441.32 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.75 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.27 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
68.00 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
217.74 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-27 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-01-27 | Hochstufung | Needham | Hold → Buy |
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Teleflex Inc. focuses on medical devices as investors watch long-term growth prospects - AD HOC NEWS
Teleflex advances heart scaffold trial, shares trade below recent highs - AD HOC NEWS
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Analysis: A Closer Look At Its 12.34% Potential Upside - DirectorsTalk Interviews
The UroLift System from Teleflex Inc.minimally invasive relief for BPH patients - AD HOC NEWS
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex (TFX) Investors? - simplywall.st
Teleflex focuses on vascular devices, peers show sector momentum - Ad-hoc-news.de
Enterprise value to EBITDA forward of Teleflex Incorporated – NYSE:TFX - TradingView
Enterprise value to EBITDA forward of Teleflex Incorporated – BX:TBH - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporat - The National Law Review
Price to sales forward of Teleflex Incorporated – NYSE:TFX - TradingView
Price to sales forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh - TradingView
Enterprise value to EBIT forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Institutional Ownership 2026 $TFX - MarketBeat
Price to earnings forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Teleflex Incorporated Actuals & Estimates (NYSE:TFX) - TradingView
Enterprise value to revenue forward of Teleflex Incorporated – NYSE:TFX - TradingView
TFX Forecast — Price Target — Prediction for 2027 - TradingView
Teleflex launches BIOMAG III trial, analyst consensus on the shares stays cautious - Ad-hoc-news.de
Enterprise value to revenue forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc (TFX) Institutional Confidence - TradingKey
Do Options Traders Know Something About Teleflex Stock We Don't? - TradingView
The Freesolve Resorbable Magnesium Scaffold from Teleflex Inc.global BIOMAG-III trial puts the co - Ad-hoc-news.de
Teleflex Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Teleflex begins enrollment in pivotal resorbable scaffold study By Investing.com - Investing.com Australia
Teleflex begins enrollment in pivotal resorbable scaffold study - Investing.com UK
Teleflex begins enrollment in BIOMAG-III pivotal study - grafa.com
Teleflex Starts Enrollment in Resorbable Magnesium Scaffold Study - Medical Product Outsourcing
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold - Business Wire
Teleflex reports muted share move, analyst metrics frame the stock - AD HOC NEWS
Teleflex Inc (TFX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teleflex Inc (TFX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Teleflex Inc (TFX) Shares Fall 4.2% -- What GF Score of 76 Tells Investors - GuruFocus
Teleflex adjusts debt profile with new senior notes, shares in focus on NYSE - AD HOC NEWS
Teleflex Inc (TFX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Irenic Capital Management LP's Teleflex Inc(TFX) Holding History - GuruFocus
Teleflex StockLong-term strategy and medical device focus - AD HOC NEWS
CVC Capital and GTCR make joint bid to take Teleflex private - Private Equity Insights
How Investors Are Reacting To Teleflex (TFX) $500 Million 5.875% Senior Notes To Fund Transformation - Sahm
Teleflex Inc (TFX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Why Teleflex's Weck EFx Shield Fascial Closure System aims to make ports safer - AD HOC NEWS
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Surgical Equipment & ConsumablesSpecialty Stocks Q1 Recap: Benchmarking Teleflex (NYSE:TFX) - Yahoo Finance
Mangrove Partners IM LLC Buys Shares of 256,726 Teleflex Incorporated $TFX - MarketBeat
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Inc. 2026 Indenture: Key Covenants, Redemption Terms, and SEC Compliance for Senior Notes - Minichart
Teleflex issues $500 million in 5.875% senior notes due 2032 By Investing.com - Investing.com Canada
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teleflex Incorporated-Aktie (TFX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Krakauer Andrew A | Director |
Aug 05 '25 |
Buy |
115.25 |
1,000 |
115,250 |
7,192 |
| Kelly Liam | Chairman, President & CEO |
Aug 05 '25 |
Buy |
115.07 |
1,500 |
172,605 |
45,267 |
| Ryu Jaewon | Director |
Aug 05 '25 |
Buy |
115.00 |
1,500 |
172,500 |
3,727 |
| HAGGERTY GRETCHEN R | Director |
Aug 06 '25 |
Buy |
114.75 |
500 |
57,375 |
6,305 |
1.68%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):